TNSN97168A1 - Composes azabicycliques condenses avec un noyeau pyridone et compositions pharmaceutiques les contenant. - Google Patents
Composes azabicycliques condenses avec un noyeau pyridone et compositions pharmaceutiques les contenant.Info
- Publication number
- TNSN97168A1 TNSN97168A1 TNTNSN97168A TNSN97168A TNSN97168A1 TN SN97168 A1 TNSN97168 A1 TN SN97168A1 TN TNSN97168 A TNTNSN97168 A TN TNSN97168A TN SN97168 A TNSN97168 A TN SN97168A TN SN97168 A1 TNSN97168 A1 TN SN97168A1
- Authority
- TN
- Tunisia
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- same
- azabicyclic compounds
- compounds condensed
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Psychology (AREA)
- Child & Adolescent Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
Abstract
L'invention concerne des composés azabicycliques condensés avec un noyau pyridone, répondant à la formule dans laquelle R1, R2 et R3 représentent divers radicaux. Elle concerne également des intermédiaires et des compositions pharmaceutiques les contenant. Application : utilisation de ces composés et compositions dans le traitement de troubles neurologiques et mentaux liés à une dimunition de la fonction cholinergique.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2880496P | 1996-10-30 | 1996-10-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
TNSN97168A1 true TNSN97168A1 (fr) | 2005-03-15 |
Family
ID=21845528
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TNTNSN97168A TNSN97168A1 (fr) | 1996-10-30 | 1997-10-29 | Composes azabicycliques condenses avec un noyeau pyridone et compositions pharmaceutiques les contenant. |
Country Status (17)
Country | Link |
---|---|
US (2) | US6235734B1 (fr) |
EP (1) | EP0937077B1 (fr) |
JP (2) | JP3621707B2 (fr) |
AP (1) | AP9701125A0 (fr) |
AR (1) | AR008901A1 (fr) |
AT (1) | ATE326468T1 (fr) |
AU (1) | AU4394897A (fr) |
DE (1) | DE69735891T2 (fr) |
ES (1) | ES2264169T3 (fr) |
GT (1) | GT199700115A (fr) |
HR (1) | HRP970567A2 (fr) |
ID (1) | ID18741A (fr) |
MA (1) | MA26445A1 (fr) |
PA (1) | PA8440201A1 (fr) |
TN (1) | TNSN97168A1 (fr) |
WO (1) | WO1998018798A1 (fr) |
ZA (1) | ZA979706B (fr) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6717030B2 (en) * | 1998-07-06 | 2004-04-06 | The Regents Of The University Of California | Protein kinase C epsilon as modulator of anxiety, alcohol consumption and self-administration of drugs of abuse |
IL137937A0 (en) * | 1999-08-27 | 2001-10-31 | Pfizer Prod Inc | A pharmaceutical composition for the prevention and treatment of nicotine addiction in a mammal |
US20010036943A1 (en) * | 2000-04-07 | 2001-11-01 | Coe Jotham W. | Pharmaceutical composition for treatment of acute, chronic pain and/or neuropathic pain and migraines |
US20020010192A1 (en) * | 2000-06-02 | 2002-01-24 | Coe Jotham Wadsworth | Pharmaceutical composition for the treatment of obesity or to facilitate or promote weight loss |
US20020016334A1 (en) * | 2000-07-31 | 2002-02-07 | Coe Jotham Wadsworth | Pharmaceutical composition for the treatment of attention deficit hyperactivity disorder (ADHD) |
RU2004116320A (ru) | 2001-11-30 | 2005-10-10 | Пфайзер Продактс Инк. (Us) | Арилконденсированные азаполициклические соединения |
SE0104463D0 (sv) * | 2001-12-29 | 2001-12-29 | Carlbiotech Ltd As | Mellanprodukter för syntes af LHRH-antagonister, sätt att framställa dem och sätt för framställning av LHRH-antagonister |
US20030162770A1 (en) | 2002-02-22 | 2003-08-28 | Davis Bonnie M. | Use of modulators of nicotinic receptors for treatment of cognitive dysfunction |
US20040224962A1 (en) * | 2003-05-09 | 2004-11-11 | Pfizer Inc | Pharmaceutical composition for the treatment of obesity or to facilitate or promote weight loss |
US20040224963A1 (en) * | 2003-05-09 | 2004-11-11 | Pfizer Inc | Pharmaceutical composition for the prevention and treatment of nicotine addiction in a mammal |
WO2005000806A2 (fr) * | 2003-06-10 | 2005-01-06 | Georgetown University | Ligands pour les recepteurs de l'acetylcholine nicotinique, et procedes de production et d'utilisation de ces ligands |
WO2005007655A1 (fr) | 2003-07-21 | 2005-01-27 | Pfizer Products Inc. | Composes azapolycycliques fusionnes avec heteroaryle pour reduire la dependance a la nicotine |
US20050234024A1 (en) * | 2004-04-14 | 2005-10-20 | Clarke David E | Materials and methods for the treatment of ulcerative colitis |
US7135933B2 (en) * | 2004-09-29 | 2006-11-14 | Intelliserv, Inc. | System for adjusting frequency of electrical output pulses derived from an oscillator |
US20090093512A1 (en) * | 2004-12-07 | 2009-04-09 | Pfizer Inc | 1, 2, 3, 3a, 8, 8a-hexahydro-2, 7a-diada-cyclopenta[a]inden-7-one derivatives which bind to neuronal nicotinic acetylcholine specific receptor sites and are useful in modulating cholinergic function and in the treatment of addictive disorders |
US20060211649A1 (en) * | 2005-03-21 | 2006-09-21 | Eric Marchewitz | Use of cytisine for enhancing physical performance |
US20070134169A1 (en) * | 2005-12-11 | 2007-06-14 | Rabinoff Michael D | Methods for smoking cessation or alcohol cessation or other addiction cessation |
WO2007100430A2 (fr) * | 2006-01-27 | 2007-09-07 | Yale University | Analogues de cystisine et d'acétylcholine et procédés de traitement des troubles de l'humeur |
WO2007115092A2 (fr) * | 2006-03-29 | 2007-10-11 | Georgetown University | Dérivés de cytisine substitués en position 10 et leurs procédés d'utilisation |
US7404725B2 (en) * | 2006-07-03 | 2008-07-29 | Hall David R | Wiper for tool string direct electrical connection |
US8061443B2 (en) * | 2008-04-24 | 2011-11-22 | Schlumberger Technology Corporation | Downhole sample rate system |
BR112012015446B1 (pt) | 2009-12-22 | 2020-02-11 | Avon Products, Inc. | Composição tópica e método para conferir um benefício antienvelhecimento à pele |
US20110159125A1 (en) | 2009-12-29 | 2011-06-30 | Avon Products, Inc. | CGRP Compositions and Uses Thereof |
FR2992315B1 (fr) * | 2012-06-25 | 2014-08-08 | Pf Medicament | Derives utiles dans le traitement de maladies du systeme nerveux central |
CA2891122C (fr) | 2012-11-14 | 2021-07-20 | The Johns Hopkins University | Methodes et compositions pour le traitement de la schizophrenie |
CN102952134B (zh) * | 2012-12-05 | 2015-01-07 | 苏州药明康德检测检验有限责任公司 | 含二氟甲基的金雀花碱衍生物及制备方法和抗癌作用研究 |
RU2630958C2 (ru) * | 2015-12-29 | 2017-09-15 | федеральное государственное автономное образовательное учреждение высшего образования "Московский физико-технический институт (государственный университет)" (МФТИ) | Новые макроциклические соединения, содержащие природное 3,7-диазабицикло[3.3.1]нонановое ядро и способ их получения |
GB201602145D0 (en) | 2016-02-05 | 2016-03-23 | Achieve Pharma Uk Ltd | Salt |
GB2558700B (en) * | 2016-08-19 | 2022-07-27 | Univ Bristol | 4-substituted Analogs of Cytisine |
CA3070055A1 (fr) | 2017-07-24 | 2019-01-31 | Achieve Pharma Uk Limited | Sels de cytisine |
EP4027815A4 (fr) * | 2019-09-12 | 2023-06-07 | Achieve Life Sciences, Inc. | Compositions comprenant de la cytisine dans le traitement et/ou la prévention de l'addiction chez des sujets en ayant besoin |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH658594A5 (de) * | 1982-02-22 | 1986-11-28 | Bruss Ni Sanitarno Gigieniches | Arzneipraeparat mit antinikotinwirkung und verfahren fuer seine herstellung. |
US4835162A (en) | 1987-02-12 | 1989-05-30 | Abood Leo G | Agonists and antagonists to nicotine as smoking deterents |
US5242916A (en) * | 1992-07-07 | 1993-09-07 | R. J. Reynolds Tobacco Company | Method for treatment of neurodegenerative diseases |
TW261531B (fr) * | 1993-10-28 | 1995-11-01 | Dynagen Inc | |
JPH11512443A (ja) * | 1995-09-22 | 1999-10-26 | ノボ ノルディスク アクティーゼルスカブ | 新規な置換アザ環式またはアザ二環式化合物 |
-
1997
- 1997-10-15 AU AU43948/97A patent/AU4394897A/en not_active Abandoned
- 1997-10-15 WO PCT/IB1997/001282 patent/WO1998018798A1/fr active IP Right Grant
- 1997-10-15 AT AT97942166T patent/ATE326468T1/de not_active IP Right Cessation
- 1997-10-15 JP JP52022898A patent/JP3621707B2/ja not_active Expired - Fee Related
- 1997-10-15 DE DE69735891T patent/DE69735891T2/de not_active Expired - Fee Related
- 1997-10-15 EP EP97942166A patent/EP0937077B1/fr not_active Expired - Lifetime
- 1997-10-15 US US09/297,109 patent/US6235734B1/en not_active Expired - Fee Related
- 1997-10-15 ES ES97942166T patent/ES2264169T3/es not_active Expired - Lifetime
- 1997-10-23 AP APAP/P/1997/001125A patent/AP9701125A0/en unknown
- 1997-10-24 HR HR60/028,804A patent/HRP970567A2/hr not_active Application Discontinuation
- 1997-10-24 PA PA19978440201A patent/PA8440201A1/es unknown
- 1997-10-27 GT GT199700115A patent/GT199700115A/es unknown
- 1997-10-28 ID IDP973538A patent/ID18741A/id unknown
- 1997-10-28 AR ARP970104980A patent/AR008901A1/es unknown
- 1997-10-29 ZA ZA979706A patent/ZA979706B/xx unknown
- 1997-10-29 MA MA24849A patent/MA26445A1/fr unknown
- 1997-10-29 TN TNTNSN97168A patent/TNSN97168A1/fr unknown
-
2001
- 2001-02-14 US US09/783,443 patent/US6630467B2/en not_active Expired - Fee Related
-
2004
- 2004-09-21 JP JP2004273910A patent/JP2005060403A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
US20030065173A1 (en) | 2003-04-03 |
ZA979706B (en) | 1999-04-29 |
JP2000505809A (ja) | 2000-05-16 |
MA26445A1 (fr) | 2004-12-20 |
US6630467B2 (en) | 2003-10-07 |
US6235734B1 (en) | 2001-05-22 |
JP2005060403A (ja) | 2005-03-10 |
AR008901A1 (es) | 2000-02-23 |
JP3621707B2 (ja) | 2005-02-16 |
ES2264169T3 (es) | 2006-12-16 |
EP0937077B1 (fr) | 2006-05-17 |
ID18741A (id) | 1998-05-07 |
HRP970567A2 (en) | 1998-10-31 |
EP0937077A1 (fr) | 1999-08-25 |
GT199700115A (es) | 1999-04-20 |
DE69735891T2 (de) | 2006-12-14 |
AP9701125A0 (en) | 1997-10-31 |
DE69735891D1 (de) | 2006-06-22 |
PA8440201A1 (es) | 2000-05-24 |
ATE326468T1 (de) | 2006-06-15 |
AU4394897A (en) | 1998-05-22 |
WO1998018798A1 (fr) | 1998-05-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TNSN97168A1 (fr) | Composes azabicycliques condenses avec un noyeau pyridone et compositions pharmaceutiques les contenant. | |
TNSN99155A1 (fr) | 1-aryl-3-arylmethyl-1,8-naphtyridine-4(1h)-ones nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant | |
TNSN99169A1 (fr) | Derives de 4,4-biarylpiperidine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
MA24729A1 (fr) | Macrolides nouveaux. | |
MA24936A1 (fr) | Procede d'emulsification | |
TNSN97192A1 (fr) | Derives de pyrimidine bicycliques condenses, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
MA26723A1 (fr) | Acides oxamiques nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
TNSN98084A1 (fr) | Derives de macrolides substitues en position c-4 | |
FI954131A (fi) | Heterosykliset yhdisteet ja niiden valmistus ja käyttö | |
MA26689A1 (fr) | Derives de tetrahydroquinoleine substitues nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
TNSN99039A1 (fr) | Bicyclo [2.2.1] heptanes nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
TNSN97056A1 (fr) | Derives de lactames, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
TNSN97198A1 (fr) | Derives de 6-phenylpyridyl-2- amine et compositions pharmaceutiques les contenant | |
TNSN97110A1 (fr) | Derives de 2-(2-oxo-ethylidene)-imidazolidine-4-one, procede pour leur preparation et compositions pharmaceutiques les contenant | |
MA26697A1 (fr) | Composes nouveaux inhibiteurs de gsk-3 et compositions pharmaceutiques les contenant | |
TNSN99236A1 (fr) | Derives bicycliques substitues nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
FR2708605A1 (fr) | Dérivés du N-sulfonylindol-2-one, leur préparation, les compositions pharmaceutiques en contenant. | |
TNSN97144A1 (fr) | Derives 6,6-heterobicycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant | |
TNSN98036A1 (fr) | Derives d'acide hexanoique nouveaux | |
TNSN98017A1 (fr) | Derives de sulfonyluree, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
TNSN99031A1 (fr) | Composes heterocycliques nouveaux inhibiteurs de romatases, procede pour leur preparation et compositions pharmaceutiques les contenant | |
TNSN98112A1 (fr) | Composes dipeptidiques | |
TNSN98024A1 (fr) | 2-amino-6-(2-substitue-4-phenoxy)-substitue-pyridines, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
FI954130A (fi) | Heterosykliset yhdisteet ja niiden valmistus ja käyttö | |
FR2708606A1 (fr) | Dérivés du N-phénylalkylindol-2-one, leur préparation, les compositions pharmaceutiques en contenant. |